Drug Type Small molecule drug |
Synonyms Perphenazine (JP17/USP/INN), Perphenazine Hydrochloride, 塩酸ペルフェナジン + [6] |
Target |
Mechanism D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (27 Feb 1957), |
Regulation- |
Molecular FormulaC21H26ClN3OS |
InChIKeyRGCVKNLCSQQDEP-UHFFFAOYSA-N |
CAS Registry58-39-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00503 | Perphenazine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Vomiting | CN | 01 Jan 1981 | |
Meniere Disease | JP | 09 Dec 1958 | |
Postoperative Nausea and Vomiting | JP | 09 Dec 1958 | |
Nausea and vomiting | US | 27 Feb 1957 | |
Schizophrenia | US | 27 Feb 1957 |
Phase 4 | 35 | kmosntbkgh(fjuwjyvxcy) = urulvvmlgy hdseiytznm (gkszqyvzeb, easgefvrni - hivwcbaqve) View more | - | 01 Mar 2021 | |||
Phase 4 | 127 | risperidone+aripiprazole+antipsychotic+paliperidone+asenapine+Olanzapine+iloperidone+lurasidone+fluoxetine+quetiapine+ziprasidone (Healthy Lifestyle Information) | mdlriwwsbd(zzcphvgikd) = reajuzxntr kwdhyyebdw (qesopwbpnj, ggahsdoprg - mxddscnuyw) View more | - | 25 Apr 2017 | ||
(Switch Treatment + Healthy Lifestyle Instruction) | mdlriwwsbd(zzcphvgikd) = urrwimcqre kwdhyyebdw (qesopwbpnj, cqegihbvdr - fbztyqrauf) View more |